- Report
- January 2025
- 180 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- August 2024
- 180 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- July 2024
- 100 Pages
Global
From €3565EUR$3,750USD£2,995GBP
- Report
- August 2024
- 130 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- December 2024
Global
From €7130EUR$7,500USD£5,990GBP
- Report
- April 2022
- 307 Pages
Global
From €5276EUR$5,550USD£4,432GBP
- Report
- June 2023
- 144 Pages
Global
From €4421EUR$4,650USD£3,714GBP
- Report
- September 2024
- 82 Pages
Japan
From €3327EUR$3,500USD£2,795GBP
- Report
- August 2024
- 80 Pages
Japan
From €3327EUR$3,500USD£2,795GBP
- Report
- August 2023
- 117 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- February 2024
- 120 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- August 2022
- 119 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- December 2023
- 250 Pages
Global
€4749EUR$4,995USD£3,989GBP
- Report
- November 2023
- 272 Pages
Global
From €3394EUR$3,570USD£2,851GBP
- Report
- February 2022
- 258 Pages
Global
From €3529EUR$3,712USD£2,965GBP
- Book
- June 2024
- 496 Pages
- Book
- December 2019
- 432 Pages
- Book
- December 2019
- 432 Pages
- Book
- November 2019
- 432 Pages
- Book
- November 2019
- 432 Pages

The Blood Disease market within the context of Hematology is a broad and diverse field of study. It encompasses a wide range of conditions, from common blood disorders such as anemia and hemophilia to rarer conditions such as thalassemia and sickle cell anemia. Hematology also covers the diagnosis and treatment of blood cancers, including leukemia, lymphoma, and multiple myeloma. In addition, hematology includes the study of blood clotting and transfusion medicine.
The Blood Disease market is a rapidly growing field, with new treatments and therapies being developed to improve patient outcomes. Companies in this market are focused on developing innovative treatments and therapies for blood diseases, as well as diagnostic tools and technologies to improve diagnosis and treatment. Examples of companies in this market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Celgene, Gilead Sciences, Novartis, and Pfizer. Show Less Read more